BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Viana F, O'Kane CM, Schroeder GN. Precision-cut lung slices: A powerful ex vivo model to investigate respiratory infectious diseases. Mol Microbiol 2021. [PMID: 34570407 DOI: 10.1111/mmi.14817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sanchez MM, Bagdasarian IA, Darch W, Morgan JT. Organotypic cultures as aging associated disease models. Aging 2022. [DOI: 10.18632/aging.204361] [Reference Citation Analysis]
2 Meineke R, Stelz S, Busch M, Werlein C, Kühnel M, Jonigk D, Rimmelzwaan GF, Elbahesh H. FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections. Viruses 2022;14:2058. [PMID: 36146864 DOI: 10.3390/v14092058] [Reference Citation Analysis]
3 Varankar SS, Cardoso EC, Lee JH. Ex situ-armus: experimental models for combating respiratory dysfunction. Curr Opin Genet Dev 2022;75:101946. [PMID: 35810725 DOI: 10.1016/j.gde.2022.101946] [Reference Citation Analysis]
4 Baldassi D, Ambike S, Feuerherd M, Cheng CC, Peeler DJ, Feldmann DP, Porras-Gonzalez DL, Wei X, Keller LA, Kneidinger N, Stoleriu MG, Popp A, Burgstaller G, Pun SH, Michler T, Merkel OM. Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes. J Control Release 2022:S0168-3659(22)00185-7. [PMID: 35364120 DOI: 10.1016/j.jconrel.2022.03.051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Hartland EL. Emerging technologies in microbiology. Mol Microbiol 2022;117:551-2. [PMID: 35303397 DOI: 10.1111/mmi.14888] [Reference Citation Analysis]
6 Meineke R, Stelz S, Busch M, Werlein C, Kühnel M, Jonigk D, Rimmelzwaan GF, Elbahesh H. Ex Vivo Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A Viruses.. [DOI: 10.1101/2022.01.19.476993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]